Skip to content

H2020

NECESSITY

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

Programme
Horizon 2020
Started
Ends
Duration
84 months
Total cost
EUR 15,820,020
EU contribution
EUR 8,200,000
Participants
28 from 11 countries
Topic
H2020_IMI2-2017-12-03
Grant agreement
806975

Coordinated by Institut National de la Sante et de la Recherche Medicale (FRFrance).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Institut National de la Sante et de la Recherche MedicaleFRFranceCoordinatorEUR 932,235known name (0.95)
Novartis Pharma AGCHSwitzerlandParticipantEUR 0PIC (1.00)
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerESSpainParticipantEUR 226,675VAT number (0.97)
Fundacion Publica Andaluza Progreso y Salud M.P.ESSpainParticipantEUR 50,000known name (0.95)
Hospital Clinic de BarcelonaESSpainThird partyNot statedknown name (0.95)
assistance publique hopitaux de parisFRFranceParticipantEUR 2,729,817name shared with others (0.80)
Association Francaise Gougerot-SjogrenFRFranceParticipantEUR 50,000PIC (1.00)
Centre Hospitalier Regional et Universitaire de BrestFRFranceThird partyNot statedknown name (0.95)
Ecrin European Clinical Research Infrastructure NetworkFRFranceParticipantEUR 815,009PIC (1.00)
Hopitaux Universitaires de StrasbourgFRFranceParticipantEUR 337,733known name (0.95)
Institut de Recherches Internationales ServierFRFranceParticipantEUR 0PIC (1.00)
Institut PasteurFRFranceParticipantEUR 118,733PIC (1.00)
Universite de Bretagne OccidentaleFRFranceParticipantEUR 427,719known name (0.95)
Universite Paris CiteFRFranceParticipantEUR 224,224known name (0.95)
Universite Paris-SaclayFRFranceThird partyNot statedknown name (0.95)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Queen Mary University of LondonGBUnited KingdomParticipantEUR 342,941PIC (1.00)
The University of BirminghamGBUnited KingdomParticipantEUR 327,402known name (0.95)
Ethniko Kai Kapodistriako Panepistimio AthinonGRGreeceParticipantEUR 130,319PIC (1.00)
University College Cork - National University of Ireland, CorkIEIrelandThird partyNot statedVAT number (0.97)
Innovation Acta SRLITItalyParticipantEUR 300,000PIC (1.00)
Universita Degli Studi di UdineITItalyParticipantEUR 100,000known name (0.95)
Academisch Ziekenhuis GroningenNLNetherlandsParticipantEUR 137,661PIC (1.00)
Universitair Medisch Centrum UtrechtNLNetherlandsParticipantEUR 196,493known name (0.95)
Helse Stavanger HfNONorwayParticipantEUR 101,397known name (0.95)
Universitetet i BergenNONorwayParticipantEUR 19,819known name (0.95)
Karolinska InstitutetSESwedenParticipantEUR 251,250known name (0.95)
Bristol-Myers Squibb Company CorpUSUnited StatesParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 28 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.